Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection WALTHAM, Mass. –(BUSINESS WIRE)–Oct. 26, 2020– PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro
